Golden State Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Golden State Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.4K	Buy	457 +1	+0.2%	+$88	﹤0.01%	782
2026 Q1	$41.3K	Sell	456 -70	-13%	-$6.42K	﹤0.01%	729
2025 Q4	$47.4K	Buy	526 +1	+0.2%	+$95	0.01%	705
2025 Q3	$51.8K	Sell	525 -49	-9%	-$4.86K	0.01%	668
2025 Q2	$52.4K	Sell	574 -103	-15%	-$9.96K	0.01%	630
2025 Q1	$76.6K	Sell	677 -18	-3%	-$1.93K	0.01%	509
2024 Q4	$73.5K	Buy	+695	New	+$74.6K	0.01%	492
2020 Q2	–	Sell	-362	Closed	-$35K	–	980
2020 Q1	$35K	Buy	+362	New	+$47.5K	0.02%	416
2019 Q4	–	Sell	-362	Closed	-$48K	–	1005
2019 Q3	$48K	Buy	362 +1	+0.3%	+$129	0.02%	439
2019 Q2	$41K	Sell	361 -1	-0.3%	-$117	0.01%	498
2019 Q1	$45K	Buy	+362	New	+$41.1K	0.02%	474

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Golden State Wealth Management's ZBH Position: Q2 2026 in Review

Golden State Wealth Management increased its Zimmer Biomet (ZBH) stake by 0.22% in Q2 2026, buying an estimated $88 and bringing the position to 457 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Golden State Wealth Management first reported a position in ZBH in Q1 2019 and has held it in 11 quarters since. The position peaked at $76.6K in Q1 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Golden State Wealth Management held 457 shares of Zimmer Biomet worth $39.4K as of Q2 2026.
Golden State Wealth Management bought 1 Zimmer Biomet share in Q2 2026, an estimated $88.
Zimmer Biomet made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #782 holding.
Golden State Wealth Management first reported a position in Zimmer Biomet in Q1 2019 and has held it in 11 quarters since.
Golden State Wealth Management's Zimmer Biomet position peaked at $76.6K in Q1 2025.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.